Review of Multiple Myeloma Genetics including Effects on Prognosis, Response to Treatment, and Diagnostic Workup.

Review of Multiple Myeloma Genetics including Effects on Prognosis, Response to Treatment, and Diagnostic Workup.
复制标题

DOI:
10.3390/life12060812
复制
发表时间:
2022-05-30
期刊:
影响因子:
3.2
通讯作者:
Bergsagel, Peter Leif
Bergsagel, Peter Leif
中科院分区:
生物学4区
文献类型:
--
作者:
Wiedmeier-Nutor, Julia Erin;Bergsagel, Peter Leif

文献摘要

参考文献

相似文献

多发性骨髓瘤是一种单克隆浆细胞疾病,是第二常见的血液恶性肿瘤。尽管使用新的治疗方案改善了生存率,但多发性骨髓瘤仍然是一种无法治愈的疾病,大多数患者会经历多次复发。多发性骨髓瘤疾病的发生和进展高度依赖于复杂的遗传畸变。本综述将总结这些遗传畸变的现有知识,它们如何影响预后和对治疗的反应,并审查敏感的分子技术用于多发性骨髓瘤检查,最终目标是早期检测骨髓瘤进展,以便及时开始治疗。
Multiple myeloma is a disorder of the monoclonal plasma cells and is the second most common hematologic malignancy. Despite improvements in survival with newer treatment regimens, multiple myeloma remains an incurable disease and most patients experience multiple relapses. Multiple myeloma disease initiation and progression are highly dependent on complex genetic aberrations. This review will summarize the current knowledge of these genetic aberrations, how they affect prognosis and the response to treatment, and review sensitive molecular techniques for multiple myeloma workup, with the ultimate goal of detecting myeloma progression early, allowing for timely treatment initiation.
DOI: 10.1111/j.1349-7006.2001.tb01142.x
发表时间: 2001-06
期刊: Japanese journal of cancer research : Gann
影响因子: --
作者:
Hanamura I;Iida S;Akano Y;Hayami Y;Kato M;Miura K;Harada S;Banno S;Wakita A;Kiyoi H;Naoe T;Shimizu S;Sonta SI;Nitta M;Taniwaki M;Ueda R
通讯作者: Ueda R
DOI: 10.1038/bcj.2017.12
发表时间: 2017-02-24
影响因子: 12.8
作者:
Chavan SS;He J;Tytarenko R;Deshpande S;Patel P;Bailey M;Stein CK;Stephens O;Weinhold N;Petty N;Steward D;Rasche L;Bauer M;Ashby C;Peterson E;Ali S;Ross J;Miller VA;Stephens P;Thanendrarajan S;Schinke C;Zangari M;van Rhee F;Barlogie B;Mughal TI;Davies FE;Morgan GJ;Walker BA
通讯作者: Walker BA
DOI: 10.1182/blood.v99.6.2185
发表时间: 2002-03-15
期刊: BLOOD
影响因子: 20.3
作者:
Avet-Loiseau, H;Facon, T;Bataille, R
通讯作者: Bataille, R
DOI: 10.1182/bloodadvances.2019001425
发表时间: 2020-05-26
期刊: BLOOD ADVANCES
影响因子: 7.5
作者:
Giri, Smith;Huntington, Scott F.;Neparidze, Natalia
通讯作者: Neparidze, Natalia
DOI: 10.1038/sj.onc.1204641
发表时间: 2001-09-10
期刊: ONCOGENE
影响因子: 8
作者:
Bergsagel, PL;Kuehl, WM
通讯作者: Kuehl, WM